Cargando…
A mainstreaming oncogenomics model: improving the identification of Lynch syndrome
INTRODUCTION: “Mainstreaming” is a proposed strategy to integrate genomic testing into oncology. The aim of this paper is to develop a mainstreaming oncogenomics model by identifying health system interventions and implementation strategies for mainstreaming Lynch syndrome genomic testing. METHODS:...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256118/ https://www.ncbi.nlm.nih.gov/pubmed/37305562 http://dx.doi.org/10.3389/fonc.2023.1140135 |
_version_ | 1785057036524847104 |
---|---|
author | O’Shea, Rosie Crook, Ashley Jacobs, Chris Kentwell, Maira Gleeson, Margaret Tucker, Katherine M. Hampel, Heather Rahm, Alanna Kulchak Taylor, Natalie Lewis, Sarah Rankin, Nicole M. |
author_facet | O’Shea, Rosie Crook, Ashley Jacobs, Chris Kentwell, Maira Gleeson, Margaret Tucker, Katherine M. Hampel, Heather Rahm, Alanna Kulchak Taylor, Natalie Lewis, Sarah Rankin, Nicole M. |
author_sort | O’Shea, Rosie |
collection | PubMed |
description | INTRODUCTION: “Mainstreaming” is a proposed strategy to integrate genomic testing into oncology. The aim of this paper is to develop a mainstreaming oncogenomics model by identifying health system interventions and implementation strategies for mainstreaming Lynch syndrome genomic testing. METHODS: A rigorous theoretical approach inclusive of conducting a systematic review and qualitative and quantitative studies was undertaken using the Consolidated Framework for Implementation Research. Theory-informed implementation data were mapped to the Genomic Medicine Integrative Research framework to generate potential strategies. RESULTS: The systematic review identified a lack of theory-guided health system interventions and evaluation for Lynch syndrome and other mainstreaming programs. The qualitative study phase included 22 participants from 12 health organizations. The quantitative Lynch syndrome survey included 198 responses: 26% and 66% from genetic and oncology health professionals, respectively. Studies identified the relative advantage and clinical utility of mainstreaming to improve genetic test access and to streamline care, and adaptation of current processes was recognized for results delivery and follow-up. Barriers identified included funding, infrastructure and resources, and the need for process and role delineation. The interventions to overcome barriers were as follows: embedded mainstream genetic counselors, electronic medical record genetic test ordering, results tracking, and mainstreaming education resources. Implementation evidence was connected through the Genomic Medicine Integrative Research framework resulting in a mainstreaming oncogenomics model. DISCUSSION: The proposed mainstreaming oncogenomics model acts as a complex intervention. It features an adaptable suite of implementation strategies to inform Lynch syndrome and other hereditary cancer service delivery. Implementation and evaluation of the model are required in future research. |
format | Online Article Text |
id | pubmed-10256118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102561182023-06-10 A mainstreaming oncogenomics model: improving the identification of Lynch syndrome O’Shea, Rosie Crook, Ashley Jacobs, Chris Kentwell, Maira Gleeson, Margaret Tucker, Katherine M. Hampel, Heather Rahm, Alanna Kulchak Taylor, Natalie Lewis, Sarah Rankin, Nicole M. Front Oncol Oncology INTRODUCTION: “Mainstreaming” is a proposed strategy to integrate genomic testing into oncology. The aim of this paper is to develop a mainstreaming oncogenomics model by identifying health system interventions and implementation strategies for mainstreaming Lynch syndrome genomic testing. METHODS: A rigorous theoretical approach inclusive of conducting a systematic review and qualitative and quantitative studies was undertaken using the Consolidated Framework for Implementation Research. Theory-informed implementation data were mapped to the Genomic Medicine Integrative Research framework to generate potential strategies. RESULTS: The systematic review identified a lack of theory-guided health system interventions and evaluation for Lynch syndrome and other mainstreaming programs. The qualitative study phase included 22 participants from 12 health organizations. The quantitative Lynch syndrome survey included 198 responses: 26% and 66% from genetic and oncology health professionals, respectively. Studies identified the relative advantage and clinical utility of mainstreaming to improve genetic test access and to streamline care, and adaptation of current processes was recognized for results delivery and follow-up. Barriers identified included funding, infrastructure and resources, and the need for process and role delineation. The interventions to overcome barriers were as follows: embedded mainstream genetic counselors, electronic medical record genetic test ordering, results tracking, and mainstreaming education resources. Implementation evidence was connected through the Genomic Medicine Integrative Research framework resulting in a mainstreaming oncogenomics model. DISCUSSION: The proposed mainstreaming oncogenomics model acts as a complex intervention. It features an adaptable suite of implementation strategies to inform Lynch syndrome and other hereditary cancer service delivery. Implementation and evaluation of the model are required in future research. Frontiers Media S.A. 2023-05-26 /pmc/articles/PMC10256118/ /pubmed/37305562 http://dx.doi.org/10.3389/fonc.2023.1140135 Text en Copyright © 2023 O’Shea, Crook, Jacobs, Kentwell, Gleeson, Tucker, Hampel, Rahm, Taylor, Lewis and Rankin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology O’Shea, Rosie Crook, Ashley Jacobs, Chris Kentwell, Maira Gleeson, Margaret Tucker, Katherine M. Hampel, Heather Rahm, Alanna Kulchak Taylor, Natalie Lewis, Sarah Rankin, Nicole M. A mainstreaming oncogenomics model: improving the identification of Lynch syndrome |
title | A mainstreaming oncogenomics model: improving the identification of Lynch syndrome |
title_full | A mainstreaming oncogenomics model: improving the identification of Lynch syndrome |
title_fullStr | A mainstreaming oncogenomics model: improving the identification of Lynch syndrome |
title_full_unstemmed | A mainstreaming oncogenomics model: improving the identification of Lynch syndrome |
title_short | A mainstreaming oncogenomics model: improving the identification of Lynch syndrome |
title_sort | mainstreaming oncogenomics model: improving the identification of lynch syndrome |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256118/ https://www.ncbi.nlm.nih.gov/pubmed/37305562 http://dx.doi.org/10.3389/fonc.2023.1140135 |
work_keys_str_mv | AT oshearosie amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT crookashley amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT jacobschris amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT kentwellmaira amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT gleesonmargaret amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT tuckerkatherinem amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT hampelheather amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT rahmalannakulchak amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT taylornatalie amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT lewissarah amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT rankinnicolem amainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT oshearosie mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT crookashley mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT jacobschris mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT kentwellmaira mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT gleesonmargaret mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT tuckerkatherinem mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT hampelheather mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT rahmalannakulchak mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT taylornatalie mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT lewissarah mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome AT rankinnicolem mainstreamingoncogenomicsmodelimprovingtheidentificationoflynchsyndrome |